ANN MARIE BURKE: Open Payments
NPI 1801364377 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,208 in 77 payments from 16 companies in 2025. Trend: 2023 $3,606 · 2024 $3,749 · 2025 $3,208
Food & beverage: $3,208
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $727 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $403 |
| Otsuka America Pharmaceutical, Inc. | 6 | $309 |
| Alkermes, Inc. | 5 | $297 |
| Vanda Pharmaceuticals Inc. | 4 | $292 |
| ABBVIE INC. | 6 | $261 |
| Neurocrine BioSciences, Inc. | 7 | $200 |
| Teva Pharmaceuticals USA, Inc. | 15 | $190 |
| Axsome Therapeutics, Inc. | 5 | $179 |
| Janssen Pharmaceuticals, Inc | 1 | $146 |
Products named: COBENFY, CAPLYTA, VRAYLAR, FANAPT, REXULTI, INGREZZA, Auvelity, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
